214 related articles for article (PubMed ID: 33290472)
1. Cu(ii) and V(iv)O complexes with tri- or tetradentate ligands based on (2-hydroxybenzyl)-l-alanines reveal promising anticancer therapeutic potential.
Ribeiro N; Bulut I; Cevatemre B; Teixeira C; Yildizhan Y; André V; Adão P; Pessoa JC; Acilan C; Correia I
Dalton Trans; 2021 Jan; 50(1):157-169. PubMed ID: 33290472
[TBL] [Abstract][Full Text] [Related]
2. Vanadium(IV) and copper(II) complexes of salicylaldimines and aromatic heterocycles: Cytotoxicity, DNA binding and DNA cleavage properties.
Correia I; Roy S; Matos CP; Borovic S; Butenko N; Cavaco I; Marques F; Lorenzo J; Rodríguez A; Moreno V; Pessoa JC
J Inorg Biochem; 2015 Jun; 147():134-46. PubMed ID: 25858461
[TBL] [Abstract][Full Text] [Related]
3. DNA binding, cleavage and cytotoxicity studies of three mononuclear Cu(II) chloro-complexes containing N-S donor Schiff base ligands.
Parsekar SU; Fernandes J; Banerjee A; Chouhan OP; Biswas S; Singh M; Mishra DP; Kumar M
J Biol Inorg Chem; 2018 Dec; 23(8):1331-1349. PubMed ID: 30302601
[TBL] [Abstract][Full Text] [Related]
4. Protein binding studies with human serum albumin, molecular docking and in vitro cytotoxicity studies using HeLa cervical carcinoma cells of Cu(ii)/Zn(ii) complexes containing a carbohydrazone ligand.
Parsekar SU; Velankanni P; Sridhar S; Haldar P; Mate NA; Banerjee A; Sudhadevi Antharjanam PK; Koley AP; Kumar M
Dalton Trans; 2020 Mar; 49(9):2947-2965. PubMed ID: 32073070
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of copper(II) complexes with Schiff bases derived from N'-tosylbenzene-1,2-diamine.
Diz M; Durán-Carril ML; Castro J; Alvo S; Bada L; Viña D; García-Vázquez JA
J Inorg Biochem; 2022 Nov; 236():111975. PubMed ID: 36055108
[TBL] [Abstract][Full Text] [Related]
6. May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents?
Matos CP; Adiguzel Z; Yildizhan Y; Cevatemre B; Onder TB; Cevik O; Nunes P; Ferreira LP; Carvalho MD; Campos DL; Pavan FR; Pessoa JC; Garcia MH; Tomaz AI; Correia I; Acilan C
Eur J Med Chem; 2019 Aug; 176():492-512. PubMed ID: 31132480
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, structural studies, interaction with DNA/HSA and antitumor evaluation of new Cu(II) complexes containing 2-(1
Cai DH; Chen BH; Liu QY; Le XY; He L
Dalton Trans; 2022 Nov; 51(43):16574-16586. PubMed ID: 36263706
[TBL] [Abstract][Full Text] [Related]
8. Monomeric and Dimeric Oxidomolybdenum(V and VI) Complexes, Cytotoxicity, and DNA Interaction Studies: Molybdenum Assisted C═N Bond Cleavage of Salophen Ligands.
Majumder S; Pasayat S; Panda AK; Dash SP; Roy S; Biswas A; Varma ME; Joshi BN; Garribba E; Kausar C; Patra SK; Kaminsky W; Crochet A; Dinda R
Inorg Chem; 2017 Sep; 56(18):11190-11210. PubMed ID: 28858483
[TBL] [Abstract][Full Text] [Related]
9. Efficient hydrolytic cleavage of DNA and antiproliferative effect on human cancer cells by two dinuclear Cu(II) complexes containing a carbohydrazone ligand and 1,10-phenanthroline as a coligand.
Parsekar SU; Singh M; Mishra DP; Antharjanam PKS; Koley AP; Kumar M
J Biol Inorg Chem; 2019 May; 24(3):343-363. PubMed ID: 30887122
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and thermal studies of tetraaza macrocylic ligand and its transition metal complexes. DNA binding affinity of copper complex.
Saif M; Mashaly MM; Eid MF; Fouad R
Spectrochim Acta A Mol Biomol Spectrosc; 2011 Sep; 79(5):1849-55. PubMed ID: 21684198
[TBL] [Abstract][Full Text] [Related]
11. Thiosemicarbazone Cu(II) and Zn(II) complexes as potential anticancer agents: syntheses, crystal structure, DNA cleavage, cytotoxicity and apoptosis induction activity.
Shao J; Ma ZY; Li A; Liu YH; Xie CZ; Qiang ZY; Xu JY
J Inorg Biochem; 2014 Jul; 136():13-23. PubMed ID: 24690556
[TBL] [Abstract][Full Text] [Related]
12. Mixed ligand copper(II) complexes of N,N-bis(benzimidazol-2-ylmethyl)amine (BBA) with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity.
Loganathan R; Ramakrishnan S; Suresh E; Riyasdeen A; Akbarsha MA; Palaniandavar M
Inorg Chem; 2012 May; 51(10):5512-32. PubMed ID: 22559171
[TBL] [Abstract][Full Text] [Related]
13. Enhancement in intramolecular interactions and in vitro biological activity of a tripodal tetradentate system upon complexation.
Tyagi N; Viji M; Karunakaran SC; Varughese S; Ganesan S; Priya S; Saneesh Babu PS; Nair AS; Ramaiah D
Dalton Trans; 2015 Sep; 44(35):15591-601. PubMed ID: 26244289
[TBL] [Abstract][Full Text] [Related]
14. Non-Linear Optical Property and Biological Assays of Therapeutic Potentials Under In Vitro Conditions of Pd(II), Ag(I) and Cu(II) Complexes of 5-Diethyl amino-2-({2-[(2-hydroxy-Benzylidene)-amino]-phenylimino}-methyl)-phenol.
Abdel-Rahman LH; Adam MS; Abu-Dief AM; Ahmed HE; Nafady A
Molecules; 2020 Nov; 25(21):. PubMed ID: 33147867
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of enantiomeric (R)- and (S)-copper(II) and diorganotin(IV)-based antitumor agents: their in vitro DNA binding profile, cleavage efficiency and cytotoxicity studies.
Arjmand F; Muddassir M; Yousuf I
J Photochem Photobiol B; 2014 Jul; 136():62-71. PubMed ID: 24857791
[TBL] [Abstract][Full Text] [Related]
16. Mixed ligand copper(II)-diimine complexes of 2-formylpyridine-
Kartikeyan R; Murugan D; Ajaykamal T; Varadhan M; Rangasamy L; Velusamy M; Palaniandavar M; Rajendiran V
Dalton Trans; 2023 Jul; 52(26):9148-9169. PubMed ID: 37341481
[TBL] [Abstract][Full Text] [Related]
17. New copper(II) and oxidovanadium(IV) complexes with a vitamin B
Balsa LM; Ferretti V; Sottile M; Nunes P; Costa Pessoa J; Correia I; León IE
Dalton Trans; 2024 Feb; 53(7):3039-3051. PubMed ID: 38111362
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, crystal structure, and cytotoxic activity of novel cyclic systems in [1,2,4]thiadiazolo[2,3-a]pyridine benzamide derivatives and their copper(II) complexes.
Adhami F; Safavi M; Ehsani M; Ardestani SK; Emmerling F; Simyari F
Dalton Trans; 2014 Jun; 43(21):7945-57. PubMed ID: 24715093
[
